Analysis | HIT-6 headache disability | SF-36v2 quality of life – PCS | SF-36v2 quality of life – MCS | |||
---|---|---|---|---|---|---|
Baseline | 12 months | Baseline | 12 months | Baseline | 12 months | |
All patients | 64.3 ± 6.6 (41–78) | 56.0 ± 11.1 (36–76) | 40.4 ± 7.4 (23.9–57.6) | 43.5 ± 10.1 (21.7–63.3) | 32.2 ± 13.7 (6.0–59.7) | 39.2 ± 15.0 (6.1–65.1) |
p < 0.0001, n = 80 | p = 0.0062, n = 79 | p = 0.0003, n = 79 | ||||
Therapeutic responders only | 64.7 ± 6.9 (41–78) | 53.2 ± 11.1 (36–74) | 39.9 ± 7.7 (23.9–57.6) | 45.2 ± 10.4 (22.3–63.3) | 32.2 ± 12.6 (14.4–57.7) | 40.8 ± 14.8 (6.1–65.1) |
p < 0.0001, n = 53 | p = 0.0001, n = 52 | p = 0.0005, n = 52 |